Staying Ahead of the Game

Applied Clinical TrialsApplied Clinical Trials-09-01-2023
Volume 32
Issue 9
Mike Hennessy Jr, President and CEO, MJH Life Sciences®

Mike Hennessy Jr, President and CEO, MJH Life Sciences®

Nothing says “end of summer” like high school football practice, apple cider, and Halloween decorations. Everyone packs up their sand chairs and boogie boards and heads back to the classroom, or workplace, whichever is most applicable. Here at MJH Life Sciences®, where education and events go hand-in-hand, our studios have been polished up all summer to bring a series of medical education programs for our physician audience. Titles such as NSCLC Insights, CKD Stakeholder Summit, and Medical Crossfire®: Expert Insights in Anti-VEGF Dosing for nAMD and DME, are all intended to help physicians improve their patients’ outcomes.

On the Industry Sciences side, MJH strives to contribute to these efforts in a different way. We inform and educate those professionals who research new compounds, investigate potential therapies in clinical trials, manufacture and distribute these drugs, and who also inform patients and healthcare professionals (HCPs) on the most appropriate ways to take advantage of
innovative drugs.

Here, in addition to events, Industry Sciences offers webcasts, digitally-enhanced “books” and magazines, videos, podcasts, and other forms of educational material for our audiences.

Some current topics that may have relevance to clinical trial professionals when peeking ahead to potential commercial viability, especially those developing hopeful advanced and curative treatments, include:

The American Medical Association reports that overall health spending was 18.3% of GDP in 2021 compared with 19.7% of GDP in 2020. That figure was down a bit, but still represents a hefty piece of the pie. Of this, 31.1% went to hospital care, 14.9% to physician services, and 8.9% to prescription drugs.

Of course with any large enterprise, complexities abound. This complexity—a constantly evolving and moving target—ensures that learning new information must take precedence for all decision-makers. Please take advantage of our many resources as you head back to work and educate yourself on all the latest issues, challenges, and strategic guidance impacting your decisions.

Thank you for reading.

Mike Hennessy Jr. is the president and CEO of Applied Clinical Trials' parent company, MJH Life Sciences®

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.